Invivyd Stock Soars 77.68% on $57.5M Public Offering

On August 26, 2025, Invivyd's stock surged by 77.68% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Invivyd, Inc. recently announced the successful closing of a $57.5 million public offering. This substantial capital raise was accompanied by the full exercise of the underwriter's option to purchase additional shares, indicating strong investor confidence in the company's prospects.

The public offering involved the sale of 89,234,480 shares of Invivyd's common stock, which has likely contributed to the recent surge in the company's stock price. This financial maneuver is expected to provide Invivyd with the necessary resources to advance its research and development initiatives, potentially leading to further growth and innovation in the biotechnology sector.